Related Experiment Video
Updated: Jun 30, 2026
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Epidemiology and risk factors of multidrug-resistant tuberculosis in Saudi Arabia: a systematic review and
Rimas Alanazi1, Hareer Alghamdi1, Raghad Alansari2
1College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Background:
Tuberculosis (TB), a major global health challenge, has been further complicated by the emergence of multidrug-resistant TB (MDR-TB), defined as resistance to at least isoniazid and rifampicin. In Saudi Arabia, TB management continues to face challenges related to population migration, demographic shifts, and comorbidities such as diabetes. Despite multiple local studies, the overall prevalence and risk factors of MDR-TB are not well established. This study aims to estimate the prevalence of MDR-TB in Saudi Arabia and identify its key risk factors.
Methods:
A systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Searches were conducted in the following databases: MEDLINE, Scopus, Web of Science, Cochrane Library, and Google Scholar. Studies published in English since 2000, involving adult TB patients tested for isoniazid and rifampicin resistance, were included. Quality was assessed using the Methodological Index for Non-Randomized Studies (MINORS) and Appraisal Tool for Cross-Sectional Studies (AXIS) tools. RStudio (v2024.09.1) was used to perform the analysis with a random-effects model, estimating pooled prevalence and odds ratios (ORs). Heterogeneity was evaluated through I 2, and publication bias was assessed using funnel plots.
Results:
Sixteen studies conducted in Saudi Arabia were included, encompassing 4,238 TB cases. The pooled prevalence of isoniazid and rifampicin resistance was 15% [95% confidence interval (CI): 7-28%] and 6% (95% CI: 3-9), respectively. MDR-TB was observed in 8% (95% CI: 4-16) of cases. Previous TB treatment was significantly associated with MDR-TB (OR = 7.34, 95% CI: 2.84-18.98, p < 0.001). In unadjusted analyses, male sex, Saudi nationality, smoking, diabetes, and pulmonary TB site were not significantly associated with MDR-TB; however, adjusted pooled analyses suggested significant associations for Saudi nationality and smoking, while diabetes remained non-significant.
Conclusion:
MDR-TB remains a significant challenge in Saudi Arabia. Standardized diagnostic protocols, enhanced treatment monitoring, and targeted preventive strategies are essential to curb resistance and improve outcomes.
Systematic Review Registration:
https://www.crd.york.ac.uk/PROSPERO/search, identifier CRD420251078514 (PROSPERO).
Related Concept Videos
01:25Mechanism of Antibiotic Resistance in MRSA
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:25Clinical Significance of Antibiotic Resistance
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...